Fig. 4From: A systematic study on the treatment of hepatitis B-related hepatocellular carcinoma with drugs based on bioinformatics and key target reverse network pharmacology and experimental verificationThe drug-gene interaction network of chemotherapeutic drugs and 6 key genes, (A) AURKA, (B) BIRC5, (C) CCNB1, (D) CDK1, (E) CDKN3 and (F) TYMS, was constructed using CTD databaseBack to article page